Immunomodulatory potential of synbiotics and phytochemicals – A Review
DOI:
https://doi.org/10.31783/elsr.2018.422230Keywords:
immunotherapy, phytochemical, phytosynbiotics, synbioticsAbstract
In the present time, the cost and side effects of commonly used synthetic medicines raise a need to develop alternative therapeutic agents. Natural/ medicinal plants and their products/ secondary metabolites are most acceptable, cost effective and safer alternatives to synthetic drugs. Various plant extracts and purified compounds have been evaluated for their biological activities like Piperine, Quercetin, Genistein, Ellagic acid and terpenoid for immunomodulatory activity. Experimental and clinical work revealed that probiotics and many medicinal plants are safe immunomodulators. Moreover, immunomodulatory efficacy of probiotics can be enhanced by prebiotics and that of medicinal plants by using their effective bioactive components rather than the whole extract. Phytosynbiotics (Prebiotic+ probiotics+ phytochemical) are a new class of food grade supplements which promote metabolic health and improve living. This review article highlights immunomodulatory activity of synbiotics and phytochemicals and their combinatorial use in the form of Phytosynbiotics, proving it a novel therapeutic agent in treatment of various diseases like diabetes, cholesterol and liver diseases. However, the undesirable side effects of medicines have been observed that have caused concern about their long term therapeutic use. This paper may throw some light to prove the ability of the Phytosynbiotics as a novel alternative or adjuvant to chemical drugs to help fight the diseases.
References
[1] P. Rachh, F. Dhabaliya, M. Rachh, K. Lakhani, A. Kanani, D. Limbani (2014) Immunomodulatory medicinal plants: A review. PhTechMed., 3: 2278.
[2] A. Bhatia, G. Kaur and H. Sekhon (2015). Anticancerous Efficacy of Betulinic acid: An Immunomodulatory phytochemica Journal of PhSciTech., 4: 39.
[3] B. Bandyopadhyay and C. M. Narayan (2014). Probiotics, Prebiotics and Synbiotics –In health improvement by modulating gut microbiota: Int. J. Curr. Microbiol. App. Sci., 3: 410-420. https://doi.org/10.20546/ijcmas.2018.709.001
[4] S. Fijan (2014). Microorganisms with claimed probiotic properties: An overview of recent
literature. Int. J. Environ. Res. Public health, 11: 4745-4767. doi:10.3390/ijerph110504745
[5] C. A. O’Bryan, D Pak, P. G. Crandall, S. O. Lee and S. C Ricke (2013). The role of prebiotics and probiotics in human health. J Prob Heal.,1: 108. doi:10.4172/2329-8901.1000108
[6] C. Zacconi, V. Bottazzi, A. Rebecchi, E. Bosi, P. G. Sarra and L. Tagliaferri (1992). Serum cholesterol levels in axenic mice colonized with Enterococcus faecium and Lactobacillus acidophilus. Microbiologica, 15: 413-417.
[7] S. Scheinbach (1998). Probiotics: functionality and commercial status. Biotechnol. Adv., 16: 581-608. doi: 10.1016/S0734-9750(98)00002-0.
[8] M. T. Liong and L G Ooi (2010) Cholesterol-lowering effects of probiotics and prebiotics: a
of review of in vivo and in vitro findings. Int J Mol Sci., 11(6): 2499-2522. doi:10.3390/ijms11062499.
[9]. K. Younis, S. Ahmad and K. Jahan (2015). Health benefits and application of prebiotics in foods. J. Food Process Tech., 6:4. doi: 10.4172/2157-7110.1000433
[10] K Shida and K. Nomoto (2013). Probiotics as efficient immunopotentiators: Translational role in cancer prevention. Indian J. Med. Res., 138: 808-814.
[11] J. J. Wessel (2009). Prebiotics, Probiotics, and Synbiotics: Functional Foods. Nutr Health,.11: 4.
[12] A. C. Ouwehand, S Salminen and E Isolauri (2002). Probiotics : an overview of beneficial effects. Antonie Van Leeuwenhoek., 82: 279-89.
[13] G. R. Gibson, E. Beatly, X. Wang and J. H. Cummings (1995). Selective stimulation of bifidobacteria in the human colony oligofructose and inulin. Gastroenterology, 108: 975-982.
[14] P. Gourbeyre, S. Denery and M. Bodinie (2011). Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J. leukoc. Biol., 89: 685-695. doi: 10.1189/jlb.1109753
[15] M. Asarat, V. Apostolopoulos, V. Vasiljevic and O. Donkor (2015). Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells. Int. J. Food Sci. Nutr., 66: 755-765. doi: 10.3109/09637486.2015.1088935
[16] K. E. Scholz-Ahrens, P. Ade, B. Marten, P. Weber, W. Timm, Y. Açil and C. C. Glüer et al., (2007). Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content and bone structure. J. Nutr., 137: 838S-846S. doi: 10.1093/jn/137.3.838S
[17] R. Watson and V. R. Preedy (2015). Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion, 1st edition, Academic Press, USA. eBook ISBN: 9780128023716.
[18] M. T. Liong and N. P. Shah (2006). Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. J Dairy Sci., 89: 1390-1399.
[19] M. Anandharaj, B. Sivasankari and R. P. Rani (2014). Effects of Probiotics, Prebiotics, and Synbiotics on Hypercholesterolemia: A Review. Chinese J Biol., doi: 10.1155/2014/572754
[20] M. D. Collins and G. R. Gibson (1999). Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nut., 69:1025S-1057S. doi: 10.1093/ajcn/69.5.1052s
[21] L. V. McFarland (2009). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol., 101: 812-822.
[22] S. Bengmark (2010). Pre-, Pro-, Synbiotics and Human Health. Food Technol. Biotechnol., 48: 464-475.
[23] A. Bhatia, A. Kaur, M. K. Randhawa and R. Singla (2012). Coencapsulation of Synbiotics as enhancer of Immunological activity: An in vivo study. J. Microbiol. Biotech. Res., 2: 606-611.
[24] B. Sreenivasa, S. P. Kumar, M. T. S. Babu, K. Ragavendra (2015). Role of synbiotics in the prevention of necrotizing enterocolitis in preterm neonates: a randomized controlled trial. Int. J. Contem. Pediatr., 2: 127-130. doi: 10.5455/2349-3291.ijcp20150512
[25] J. Romeo, E. Nova, J. Wärnberg, S. Gómez-Martínez, L. E. Díaz Ligia and A. Marcos (2010). Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr. Hosp., 25: 341-349.
[26] H. J. Hamasalim (2016). Synbiotic as feed additives relating to animals health and performance. Adv in Microbiol., 6: 288-302. doi: 10.4236/aim.2016.64028
[27] F. Guarner and J. R. Malagelada (2016). Gut flora in health and disease. Lancet., 361: 512-519.
[28] E. Bauer, B. A. Williams, H. Smidt, M. W. Verstegen and R. Mosenthin (2011). Influence of the gastrointestinal microbiota on development of the immune system in young animals. Curr. Issues Intest. Microbiol., 7: 35-51.
[29] C. Palmer, E. M. Bik, D. B. DiGiulio, D. A. Relman and P. O. Brown (2007). Development of the human infant intestinal microbiota. PloS Biol., 5: e177. doi:10.1371/journal.pbio.0050177
[30] M. A. Roller, G. Pietro Fermia, Caderni, G. Rechkemmer, and B. Watzl (2004). Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr., 92: 931-938.
[31] D. Gabrilovich and V Pisarev (2003). Tumor escape from immune response: mechanisms and targets of activity. Curr. Drug Tar., 4: 525-536.
[32] E. Furrie, S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O’Neil and G. T. Macfarlane (2005). Synbiotic therapy (bifidobacterium longum/ Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomized controlled pilot trail. Gut., 54: 242-249.
[33] E. J. Schiffrin, D. Brassart, A. L. Servin, F. Rochat and A. Donnet-Hughes (1997). Immunomodulationof blood leukocytes in humans by lactic acid bacteria criteria for strain selection. Am. J. Clin. Nutr., 66: 515S-520S.
[34] M. L. Cross (2002). Microbes versus microbes: immune signals generated by probiotic Lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol., 34: 245-253
[35] P. J. Delves and I. M. Roitt (2000). The immune system. N. Engl. J .Med., 343: 37-49.
[36] M. Saarela (2009). Probiotics as ingredients in functional beverages. In Functional and speciality beverage technology (pp. 55-70).
[37] A. Sullivan and C. E. Nord (2002). Probiotics in human infections. J. Antimicrob. Chemother., 50: 625-627.
[38] V. Rosenfeldt, E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen and N. H. Valerius et l., (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J.Allergy.Clin. Immunol., 111: 389-395.
[39] N. Bloksma, E. de Heer, H. van Dijk and J. M. Willers (1979). Adjuvanticity of Lactobacilli. Differential effects of viable and killed bacteria, Clin. Exp. Immunol., 37: 367-375.
[40] I .Kato, T Yokokura and M. Mutai (1983). Macrophage activation by Lactobacillus casei in mice. Microbial. Immunol., 27: 611-618.
[41] S. N. Meydani and W. K. Ha (2000). Immunologic effects of yogurt. Am. J. Clin. Nutr. 71: 861-872.
[42] A. Kishi., K Uno,Y.Matsubara, C Okuda and T Kishida (1996). Effect of oral administration of Lactobacillus brevis subsp coagulans on interferon-alpha producing capacity in humans. J. Am. Coll. Nutr., 15: 408-412.
[43] T. Ogawa, S. Hashikawa, S. H. Sakamoto, K. Yasuda and Makimura (2006) A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS-Immunol. Med. Microbiol., 46: 400-9.
[44] K. Kukkonen, E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela and T. Poussa et al., (2007). Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy.clin.Immunol., 119: 192-198.
[45] C. Dupont, J. Hol and E. E. Nieuwenhuis (2015). Cow’s Milk Allergy Modified by Elimination and Lactobacilli study group. An extensively hydrolysed caseinbased formula for infants with cows’ milk protein allergy: tolerance/hypoallergenicity and growth catch-up. Br. J. Nutr., 113: 1102-1112.
[46] Z. Asemi, Z. Zare, H. Shakeri, S. S. Sabihi and A. Esmaillzadeh (2013). Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nut. Metab., 63: 1-9.
[47] J. Sethi and J Singh (2015). Role of medicinal plants as immunostimulants in health and disease. Ann.Med.Chem.Res,. 1: 1009.
[48] P. K. Mukherjee, N. K. Nema, S. Bhadra, D. Mukherjee, F. C. Braga and M. G. Matsabisa (2014). Immunomodulatory leads from medicinal plants. Indian J.Traditional Knowledge, 13: 235-56.
[49] N. I. Hahn (1998). Are phytoestrogens nature’s cure for what ails Us? A Look at the research.
research. J. Am. Diet. Assoc., 98: 974-976.
[50] A. R. Chowdhury., S. Mandal, B. Mittra, S. Sharma, S. Mukhopadhyay and H. K. Majumder (2002). Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med. Sci. Monit., 8: 254-65.
[51] P. Foti, D. Erba, P. Riso, A. Spadafranca, F. Criscuoli and G. Testolin (2005). Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arc. Biochem. Biophys.433: 421-427.
[52] S. J. Kim, S. Y. Cho, S. H. Kim, O. J. Song, S. Shin and D. S. Cha et al., (2008). Effect of microencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT-Food Sci Tech., 41: 493-500. doi: 10.1016/j.lwt.2007.03.025
[53] P. Swathi, E. Kumar E., J. Kumar T., and C. H. Vijay (2012). Evaluation of antihyperglycemic and antilipidemic activity of ehhonolic extracts of Tylophora indica in alloxan induced diabetic rats. Int. J. Curr. Pharma. Res., 4: 25-31.
[54] L. Wang, D. Zhao, Z. Zhang, C. Zuo, Y. Zhang and Y. Q. Pei et al., (1999). Trial of antiepilepsirine (AES) in children with epilepsy. Brain Dev., 21: 36-40.
[55] C. Senecha, P. Shama K., U. Prakash D’Souza and C. S. Shastry (2012). Anticholesteremic and Antilipidemic activity of Stem bark extracts of Moringa oleifera in Diet induced hyperlipidemia model in rats. Int. J. Pharma. Chem. Sci., 1: 916-923.
[56] J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa, M. J Yáñez-Gascón, F. J. García-Almagro and J. A. Ruiz-Ros (2013). Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N. Y. Acad Sci., 1290: 37-51.
[57] S. Kumar, S. Sharma and N. Vasudeva (2013). Screening of antidiabetic and antihyperlipidemic potential of oil from Piper longum and piperine with their possible mechanism. Expert Opin. Pharmacother., 13: 1723-1736.
[58] W. E. Ho, H. Y. Peh, T. K. Chan and W. S. Wong (2014). Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol. Ther., 142: 126-139.
[59] S. Thakur, K. L. Tiwari and S. K. Jadhav (2015). Approaches for Conservation o an Ethnomedicinal Plant: Asparagus racemosus Willd. J. Biological Sci., 15: 126-133.
[60] C. B. Tat (2013). Phytosynbiotics: Balance your gut and achieve better health-A Report. Freshwerkz Pte Ltd, Singapore. http://www.provieg.com/docs/Phytosynbiotics.pdf
[61] Shipradeep, S. Karmakar, R. S. Khare, S. Ojha, K. Kundu and S. Kundu.(2012) Development of probiotic candidate in combination with essential oils from medicinal plant and their effect on enteric pathogens: A Review. Gastroenterol. Res.Pract., 2012: doi: 10.1155/2012/457150
[62] S. Hooshmand., S. Juma and B. Arjmandi. (2010) Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency. J. Med. Food., 13: 320-325.
[63] S. Daniells (2014). Calcium and prebiotic combination boost the bone health than prebiotic alone: Human data. https://www.nutraingredients-usa.com/Article/2014/01/24/Calcium-prebiotic-combination-may-boost-bone-health-more-than-calcium-alone-Human-data?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Author (s)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright © The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are properly credited, and the work is not modified or adapted.
